by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic cancer respond to immunotherapies. Researchers have discovered race-associated molecular differences in tumors that may impact the way...
by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
Li-Yuan Bai, M.D., M.M.S., Ph.D. Li-Yuan Bai, M.D., M.M.S., Ph.D.
by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials
/PRNewswire/ — GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for… /PRNewswire/ — GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced...
by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials
Conditions: Intestinal Health Interventions: Dietary Supplement: Probiotic; Dietary Supplement: Placebo Sponsors: Wecare Probiotics Co., Ltd. Not yet recruiting Conditions: Intestinal Health Interventions: Dietary Supplement: Probiotic; Dietary Supplement: Placebo...
by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials
Jason M. Hafron, MD, CMO, discusses recent approvals in the non–muscle-invasive bladder cancer space and data from several clinical trials evaluating agents for bladder cancer. Jason M. Hafron, MD, CMO, discusses recent approvals in the non–muscle-invasive bladder...
by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials
/PRNewswire/ — Advarra, the market leader in regulatory review solutions and clinical research technology, today announced the launch of Oncology Research… /PRNewswire/ — Advarra, the market leader in regulatory review solutions and clinical...